Biomics Biopharma (ASX:BBM) FCF Margin %: 0.00% (As of . 20)


What is Biomics Biopharma FCF Margin %?

Biomics Biopharma ASX:BBM FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biomics Biopharma's Free Cash Flow for the six months ended in . 20 was A$0.00 Mil. Biomics Biopharma's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, Biomics Biopharma's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Biomics Biopharma's current FCF Yield % is 0.00%.

The historical rank and industry rank for Biomics Biopharma's FCF Margin % or its related term are showing as below:


ASX:BBM's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Biomics Biopharma FCF Margin % Related Terms

Biomics Biopharma FCF Margin % Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma FCF Margin % Chart

Biomics Biopharma Annual Data
Trend
FCF Margin %

Biomics Biopharma Semi-Annual Data
FCF Margin %

Biomics Biopharma FCF Margin % Competitor Comparison

For the Biotechnology subindustry, Biomics Biopharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomics Biopharma FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's FCF Margin % falls into.


Biomics Biopharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biomics Biopharma's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Biomics Biopharma's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Biomics Biopharma (ASX:BBM) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biomics Biopharma and its competitors.
Is Biomics Biopharma's FCF Margin % too high?
Biomics Biopharma's current FCF Margin % is 0.00%.
How does Biomics Biopharma's FCF Margin % compare to competitors?
Biomics Biopharma's FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biomics Biopharma and its competitors. Biomics Biopharma's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.